POS1246 EFFECTS OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN SUBGROUPS BY DISEASE ACTIVITY INDEX | Publicación